The dilemma of the nonthyroidal illness syndrome

Acta Biomedica de l'Ateneo Parmense

Volumn 79, Issue 3, 2008, Pages 165-171

  Lechan, Ronald M ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ENDOTOXIN; LEPTIN; LIOTHYRONINE; NEUROPEPTIDE Y; PROTIRELIN; THYROID HORMONE; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE; THYROXINE DEIODINASE TYPE 1; THYROXINE DEIODINASE TYPE 2; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ARCUATE NUCLEUS; CONTINUOUS INFUSION; DISEASE SEVERITY; EDITORIAL; ENZYME ACTIVITY; EUTHYROID SICK SYNDROME; EUTHYROIDISM; FEEDBACK SYSTEM; GENE EXPRESSION; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; HYPOTHYROIDISM; INTENSIVE CARE UNIT; LIVER; MORTALITY; NERVE CELL; PATHOPHYSIOLOGY; PREDICTION; PROTEIN EXPRESSION; RNA TRANSLATION; SCORING SYSTEM; TANYCYTE; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; ANIMAL; BLOOD; CRITICAL ILLNESS; DIET RESTRICTION; DISEASE MODEL; GENETICS; HOMEOSTASIS; HYPOTHALAMUS; MOUSE; PHYSIOLOGY; RABBIT; RAT; SECRETION; SYNDROME;

ANIMALS; ARCUATE NUCLEUS; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; EUTHYROID SICK SYNDROMES; FASTING; GENE EXPRESSION; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; INTENSIVE CARE UNITS; LEPTIN; MICE; RABBITS; RATS; SYNDROME; THYROID HORMONES;

EID: 63049139501     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (59)

1. Plikat K, Langgartner J, Buettner R, et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism 2007; 56: 239-244 (Pubitemid 46074071)
2. Rothwell PM, Lawler PG. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995; 23: 78-83.
3. De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin 2006; 22: 57-86. (Pubitemid 43037110)
4. Adler SM, Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am 2007; 36: 657-672 (Pubitemid 47135590)
5. Silva JE. The thermogenic effect of thyroid hormone and its clinical implications. Ann Intern Med 2003; 139: 205-213 (Pubitemid 38124603)
6. Bianco AC, Carvalho SD, Carvalho CR, Rabelo R, Moriscot AS. Thyroxine 5′-deiodination mediates norepinephrine- induced lipogenesis in dispersed brown adipocytes. Endocrinology 1998; 139: 571-578 (Pubitemid 28513205)
7. Oppenheimer JH, Schwartz HL, Lane JT, Thompson MP. Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. J Clin Invest 1991; 87: 125-132
8. Kong WM,Martin NM, Smith KL, et al.Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. Endocrinology 2004; 145: 5252-5258 (Pubitemid 39551147)
9. Lechan RM, Kakucska I. Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the hypothalamic paraventricular nucleus. Ciba Found Symp 1992; 168: 144-158
10. Perello M, Friedman T, Paez-Espinosa V, Shen X, Stuart RC, Nillni EA. Thyroid hormones selectively regulate the posttranslational processing of prothyrotropin-releasing hormone in the paraventricular nucleus of the hypothalamus. Endocrinology 2006; 147: 2705-2716 (Pubitemid 43764607)
11. Lechan RM, Kakucska I. Feedback regulation of thyrotropin-releasing hormone gene expression by thyroid hormone in the hypothalamic paraventricular nucleus. In: Functional Anatomy of the Neuroendocrine Hypothalamus, Ciba foundation Symposium 168. John Wiley & Sons Ltd, Chichester; 1992: 144-164
12. Mori M, Yamada M. Thyroid hormones regulate the amount of thyrotrophin-releasing hormone in the hypothalamic median eminence of the rat. J Endocrinol 1987; 114: 443-448 (Pubitemid 17130209)
13. Dahl GE, Evans NP, Thrun LA, Karsch FJ. A central negative feedback action of thyroid hormones on thyrotropinreleasing hormone secretion. Endocrinology 1994; 135: 2392-2397 (Pubitemid 24377393)
14. Rondeel JM, de Greef WJ, Klootwijk W, Visser TJ. Effects of hypothyroidism on hypothalamic release of thyrotropin-releasing hormone in rats. Endocrinology 1992; 130: 651-656
15. Koller KJ, Wolff RS, Warden MK, Zoeller RT. Thyroid hormones regulate levels of thyrotropin-releasing-hormone mRNA in the paraventricular nucleus. Proc Natl Acad Sci USA 1987; 84: 7329-7333 (Pubitemid 18017339)
16. Martin JB, Boshans R, Reichlin S. Feedback regulation of TSH secretion in rats with hypothalamic lesions. Endocrinology 1970; 87: 1032-1040
17. Kaplan MM, Taft JA, Reichlin S, Munsat TL. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis. J Clin Endocrinol Metab 1986; 63: 808-814 (Pubitemid 16004278)
18. Rodriguez-Perez A, Palos-Paz F, Kaptein E, et al. Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clin Endocrinol (Oxf ) 2008; 68: 821-827
19. Peeters RP,Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 2003; 88: 3202-3211 (Pubitemid 36877495)
20. Debaveye Y, Ellger B, Mebis L, et al.Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2. Endocrinology 2005; 146: 5604-5611 (Pubitemid 41653077)
21. Fekete C, Lechan RM.Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Front Neuroendocrinol 2007; 28: 97-114. (Pubitemid 47033939)
22. Lechan RM, Fekete C. The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res 2006; 153: 209-235 (Pubitemid 44107417)
23. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-252 (Pubitemid 26251358)
24. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. Leptin prevents fasting-induced suppression of prothyrotropin- releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997; 138: 2569-2576 (Pubitemid 27215264)
25. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003; 111: 1409-1421 (Pubitemid 36554712)
26. Chan JL, Matarese G, Shetty GK, et al. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. Proc Natl Acad Sci USA 2006; 103: 8481-8486 (Pubitemid 43838481)
27. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 2002; 87: 2391-2394 (Pubitemid 34521535)
28. Lechan RM, Fekete C. Feedback regulation of thyrotropin-releasing hormone (TRH): mechanisms for the non-thyroidal illness syndrome. J Endocrinol Invest 2004; 27: 105-119
29. Fekete C, Legradi G, Mihaly E, et al. alpha-Melanocytestimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci 2000; 20: 1550-1558 (Pubitemid 30220433)
30. Sarkar S, Légrádi G, Lechan RM. Intracerebroventricular administration of alpha-melanocyte stimulating hormone increases phosphorylation of CREB in TRH- and CRHproducing neurons of the hypothalamic paraventricular nucleus. Brain Res 2002; 945: 50-59 (Pubitemid 34756576)
31. Fekete C, Kelly J, Mihaly E, et al. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology 2001; 142: 2606-2613 (Pubitemid 32473117)
32. Fekete C, Marks DL, Sarkar S, et al. Effect of Agouti-Related Protein (Agrp) in Regulation of the Hypothalamic- Pituitary-Thyroid (Hpt) Axis in the Mc4-R Ko Mouse. Endocrinology 2004. (Pubitemid 39551096)
33. Lechan RM, Fekete C. Role of melanocortin signaling in the regulation of the hypothalamic-pituitary-thyroid (HPT) axis. Peptides 2006; 27: 310-325 (Pubitemid 43168170)
34. Harris M, Aschkenasi C, Elias CF, et al. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 2001; 107: 111-120 (Pubitemid 32047420)
35. Gardner DF, Kaplan MM, Stanley CA, Utiger RD. Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 1979; 300: 579-584 (Pubitemid 9123117)
36. Burman KD,Wartofsky L, Dinterman RE, Kesler P,Wannemacher RW, Jr. The effect of T3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion. Metabolism 1979; 28: 805-813
37. Sergeyev V, Broberger C, Hokfelt T. Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Brain Res Mol Brain Res 2001; 90: 93-100. (Pubitemid 32537630)
38. Fliers E, Guldenaar SEF,Wiersinga WM, Swaab DF. Decreased Hypothalamic Thyrotropin-Releasing Hormone Gene Expression in Patients with Nonthyroidal Illness. J Clin Endocrinol Metab 1997; 82: 4032-4036 (Pubitemid 27525507)
39. Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 2002; 56: 655-669
40. Bacci V, Schussler GC, Kaplan TB. The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab 1982; 54: 1229-1235 (Pubitemid 13238706)
41. Fekete C, Gereben B, Doleschall M, et al. Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology 2004; 145: 1649-1655 (Pubitemid 38402371)
42. Fekete C, Sarkar S, Christoffolete MA, Emerson CH, Bianco AC, Lechan RM. Bacterial lipopolysaccharide (LPS)-induced type 2 iodothyronine deiodinase (D2) activation in the mediobasal hypothalamus (MBH) is independent of the LPS-induced fall in serum thyroid hormone levels. Brain Res 2005; 1056: 97-99
43. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23: 38-89. (Pubitemid 34185306)
44. Lechan RM, Fekete C. Infundibular tanycytes as modulators of neuroendocrine function: hypothetical role in the regulation of the thyroid and gonadal axis. Acta Biomed 2007; 78 (Suppl 1): 84-98.
45. Kakucska I, Rand W, Lechan RM. Thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is dependent upon feedback regulation by both triiodothyronine and thyroxine. Endocrinology 1992; 130: 2845-2850
46. Crantz FR, Silva JE, Larsen PR. An analysis of the sources and quantity of 3,5,3′-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 1982; 110: 367-375 (Pubitemid 12162924)
47. Riskind PN, Kolodny JM, Larsen PR. The regional hypothalamic distribution of type II 5′-monodeiodinase in euthyroid and hypothyroid rats. Brain Res 1987; 420: 194-198 (Pubitemid 17151318)
48. Tu HM, Kim SW, Salvatore D, et al. Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 1997; 138: 3359-3368 (Pubitemid 27345689)
49. Fliers E, Unmehopa UA, Alkemade A. Functional neuroanatomy of thyroid hormone feedback in the human hypothalamus and pituitary gland. Mol Cell Endocrinol 2006; 251: 1-8. (Pubitemid 43728839)
50. Rodriguez EM, Blazquez JL, Pastor FE, et al. Hypothalamic tanycytes: a key component of brain-endocrine interaction. Int Rev Cytol 2005; 247: 89-164. (Pubitemid 41782012)
51. Puymirat J. Thyroid receptors in the rat brain. Prog Neurobiol 1992; 39: 281-294
52. Coppola A, Liu ZW, Andrews ZB, et al. A central thermogenic- like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2. Cell metabolism 2007; 5: 21-33. (Pubitemid 44939398)
53. Haas NA, Camphausen CK, Kececioglu D. Clinical review: thyroid hormone replacement in children after cardiac surgery - is it worth a try? Crit Care 2006; 10: 213.
54. Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63: 1-8. (Pubitemid 16093000)
55. Becker RA, Vaughan GM, Ziegler MG, et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 1982; 10: 870-875
56. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995; 333: 1522-1527
57. Spratt DI, Frohnauer M, Cyr-Alves H, et al. Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery. Am J Physiol Endocrinol Metab 2007; 293: E310-5.
58. Pingitore A, Galli E, Barison A, et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2008; 93: 1351-1358
59. Van den Berghe G,Wouters P,Weekers F, et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 1999; 84: 1311-1323 (Pubitemid 30644393)